Literature DB >> 21471843

Results of a prospective randomized study comparing a novel retractor with a Caspar retractor in anterior cervical surgery.

Ananthababu Pattavilakom1, Kevin A Seex.   

Abstract

BACKGROUND: Retraction injury might explain the soft tissue complications seen after anterior cervical surgery. A novel retractor system (Seex retractor system [SRS]) that uses a principle of bone fixation with rotation has been shown to reduce retraction pressure in a cadaveric model of anterior cervical decompression and fusion.
OBJECTIVE: To compare the conventional Cloward-style retractor (CRS) with the SRS in a prospective randomized clinical trial.
METHODS: After ethics and study registration (ACTRN 12608000430336), eligible patients were randomized to either the CRS or SRS before 1- or 2-level anterior cervical decompression and fusion. The pressure beneath the medial retractor blade was recorded with a thin pressure transducer strip. Postoperative sore throat, dysphagia, and dysphonia were assessed after 1, 7, and 28 days.
RESULTS: Twenty-six patients were randomized. There were no serious complications. Complication rates were low with a trend favoring SRS that was not statistically different. Average retraction pressure with SRS was 1.9 mm Hg and with CRS was 5.6 mm Hg (P < .001 on F test; P = .002 on 2-tailed t test). Mean average peak retraction pressure with the SRS was 3.4 mm Hg and with the CRS was 20 mm Hg (P < .001 on F test; P = .005 on 2-tailed t test).
CONCLUSION: The new retractor is safe, and statistically similar complication rates were observed with the 2 systems. The SRS generated significantly less retraction pressure compared with the CRS. This difference can be explained by the different principles governing the function of these retractors. Bone fixation gives stability and rotation reduces tissue pressure, both desirable in a retractor.

Entities:  

Mesh:

Year:  2011        PMID: 21471843     DOI: 10.1227/NEU.0b013e318219565f

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Intravenous and local steroid use in the management of dysphagia after anterior cervical spine surgery: a systematic review of prospective randomized controlled trails (RCTs).

Authors:  Jingwei Liu; Yiqi Zhang; Yong Hai; Nan Kang; Bo Han
Journal:  Eur Spine J       Date:  2018-11-30       Impact factor: 3.134

2.  Current strategies of reduce the rate of dysphagia and dysphonia after anterior cervical spine surgery and role of corticosteroids.

Authors:  Dong Chen; Min-Min Shao; Xiang-Yang Wang; Yan Michael Li; Ai-Min Wu
Journal:  Ann Transl Med       Date:  2018-12

Review 3.  The retropharyngeal steroid use during operation on the fusion rate and dysphagia after ACDF? A systematic review and meta-analysis.

Authors:  Jipeng Song; Ping Yi; Yanlei Wang; Long Gong; Yan Sun; Feng Yang; Xiangsheng Tang; Mingsheng Tan
Journal:  Eur Spine J       Date:  2021-11-06       Impact factor: 3.134

4.  Risk factors and preventative measures of early and persistent dysphagia after anterior cervical spine surgery: a systematic review.

Authors:  Jingwei Liu; Yong Hai; Nan Kang; Xiaolong Chen; Yangpu Zhang
Journal:  Eur Spine J       Date:  2017-10-07       Impact factor: 3.134

5.  Comparison among perfect-C®, zero-P®, and plates with a cage in single-level cervical degenerative disc disease.

Authors:  Sung Hyun Noh; Ho Yeol Zhang
Journal:  BMC Musculoskelet Disord       Date:  2018-01-25       Impact factor: 2.362

6.  Intervertebral-spreader-assisted anterior cervical discectomy and fusion prevents postoperative axial pain by alleviating facet joint pressure.

Authors:  Chen Xu; Ruizhe Wang; Jingchi Li; Huajian Zhong; Zifang Zhang; Cheng Cui; Baifeng Sun; Ye Tian; Huajiang Chen; Xiaolong Shen; Yang Liu; Wen Yuan
Journal:  J Orthop Surg Res       Date:  2022-02-15       Impact factor: 2.359

Review 7.  Oropharyngeal Dysphagia after anterior cervical spine surgery: a review.

Authors:  Karen K Anderson; Paul M Arnold
Journal:  Global Spine J       Date:  2013-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.